J. Salvini

PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients

A. Chella, L. Landi, C. Tibaldi, 2014, British Journal of Cancer.

MET overexpression and gene amplification in NSCLC: a clinical perspective.

L. Landi, A. D’Incecco, G. Minuti, 2013, Lung Cancer.

MicroRNA signature in metastatic colorectal cancer patients treated with anti-EGFR monoclonal antibodies.

L. Landi, A. D’Incecco, G. Fontanini, 2014, Clinical colorectal cancer.

Activity of the EGFR-HER2 dual inhibitor afatinib in EGFR-mutant lung cancer patients with acquired resistance to reversible EGFR tyrosine kinase inhibitors.

L. Landi, C. Tibaldi, A. D’Incecco, 2014, Clinical Lung Cancer.

Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study

M. Todaro, G. Stassi, L. Landi, 2015, PloS one.

Activity of the EGFR-HER2 dual inhibitor afatinib in EGFR-mutant lung cancer patients with acquired resistance to reversible EGFR tyrosine kinase inhibitors.

L. Landi, C. Tibaldi, A. D’Incecco, 2014, Clinical lung cancer.

Changes in PTGS1 and ALOX12 Gene Expression in Peripheral Blood Mononuclear Cells Are Associated with Changes in Arachidonic Acid, Oxylipins, and Oxylipin/Fatty Acid Ratios in Response to Omega-3 Fatty Acid Supplementation

M. Todaro, G. Stassi, L. Landi, 2015, PloS one.